MedTrace Logo

Investigation for Health Efficacy of Infrared-C Radiation on Diabetes Patients in Senior's Activity Center

NCT04177420 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2019-11-26

No results posted yet for this study

Summary

Hyperglycemia caused by diabetes will bring us the long-term damage，it causes glycation. The combination of sugar molecules and protein molecules will transform to advanced glycation end products (AGEs) and produce a lot of free radicals to caused inflammatory reactions, forming various comorbidities, affecting the function of different organs, especially the eyes, kidneys, nervous system, heart, blood vessels and damage to bone structure and bone Quality, which leads to bone loss. Therefore, the development of alternative therapies is important for the treatment of diabetes. We assume the 4 months experiment can normalize subjects HbA1c.

Conditions

  • Diabetes Mellitus, Type 2

Interventions

DEVICE

FIR-C mattress

infrared-C irradiation by hot mattress with a powered heating compress

DEVICE

FIR-C abdominal pad

infrared-C irradiation by hot abdominal pad with a powered heating compress

DEVICE

fake FIR-C mattress

normal mattress with fake controller, custom make for placebo group

DEVICE

fake FIR-C abdominal pad

normal abdominal pad with fake controller, custom make for placebo group

Sponsors & Collaborators

  • Buddhist Dalin Tzu Chi General Hospital

    collaborator UNKNOWN

  • Solano Semiconductor Technology., LTD.

    collaborator UNKNOWN

  • Nanhua University

    lead OTHER

Principal Investigators

  • Ching Yong Chin, Master · Nanhua University

  • Yi-Wen Huang, Master · Nanhua University

  • Jin-Bang Shang, Master · Nanhua University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-23
Primary Completion
2019-12-31
Completion
2020-02-15

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04177420 on ClinicalTrials.gov